Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-20-052511

Director sold 3,250 shares at $17.25 ($56,063)

From the SEC's structured data for this filing

Trades in this filing

Ajer Jeffrey Robert · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-09-28 Sale : show line 1 in the form −3,250 $17.25 $56,063 25,975 D
Open-market sales · 3,250 sh · avg $17.25 · $56,063
Loading xslF345X03/doc4.xml…